134 related articles for article (PubMed ID: 11228358)
1. Enhancement of VP1-specific immune responses and protection against EMCV-K challenge by co-delivery of IL-12 DNA with VP1 DNA vaccine.
Suh YS; Ha SJ; Lee CH; Sin JI; Sung YC
Vaccine; 2001 Feb; 19(15-16):1891-8. PubMed ID: 11228358
[TBL] [Abstract][Full Text] [Related]
2. Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: effect of coinjection with a granulocyte-macrophage colony stimulating factor gene.
Sin JI; Sung JH; Suh YS; Lee AH; Chung JH; Sung YC
Vaccine; 1997 Dec; 15(17-18):1827-33. PubMed ID: 9413089
[TBL] [Abstract][Full Text] [Related]
3. Protective immune response in mice vaccinated with a recombinant adenovirus containing capsid precursor polypeptide P1, nonstructural protein 2A and 3C protease genes (P12A3C) of encephalomyocarditis virus.
Chen Z; Guo X; Ge X; Jia H; Yang H
Vaccine; 2008 Jan; 26(4):573-80. PubMed ID: 18162265
[TBL] [Abstract][Full Text] [Related]
4. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus.
Wu CN; Lin YC; Fann C; Liao NS; Shih SR; Ho MS
Vaccine; 2001 Dec; 20(5-6):895-904. PubMed ID: 11738755
[TBL] [Abstract][Full Text] [Related]
5. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity.
Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM
J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362
[TBL] [Abstract][Full Text] [Related]
6. Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo.
Sin JI; Kim JJ; Zhang D; Weiner DB
Hum Gene Ther; 2001 Jun; 12(9):1091-102. PubMed ID: 11399230
[TBL] [Abstract][Full Text] [Related]
7. IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge.
Sin JI; Kim JJ; Arnold RL; Shroff KE; McCallus D; Pachuk C; McElhiney SP; Wolf MW; Pompa-de Bruin SJ; Higgins TJ; Ciccarelli RB; Weiner DB
J Immunol; 1999 Mar; 162(5):2912-21. PubMed ID: 10072541
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
Wang X; Zhang X; Kang Y; Jin H; Du X; Zhao G; Yu Y; Li J; Su B; Huang C; Wang B
Vaccine; 2008 Sep; 26(40):5135-44. PubMed ID: 18462848
[TBL] [Abstract][Full Text] [Related]
9. Immunization of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus.
Fan H; Tong T; Chen H; Guo A
Virus Genes; 2007 Oct; 35(2):347-57. PubMed ID: 17497212
[TBL] [Abstract][Full Text] [Related]
10. LFA-3 plasmid DNA enhances Ag-specific humoral- and cellular-mediated protective immunity against herpes simplex virus-2 in vivo: involvement of CD4+ T cells in protection.
Sin JI; Kim J; Dang K; Lee D; Pachuk C; Satishchandran C; Weiner DB
Cell Immunol; 2000 Jul; 203(1):19-28. PubMed ID: 10915558
[TBL] [Abstract][Full Text] [Related]
11. Prevention of encephalomyocarditis virus-induced diabetes by live recombinant Mycobacterium bovis bacillus Calmette-Guérin in susceptible mice.
Choi BK; Cho SH; Bai GH; Kim SJ; Hyun BH; Choe YK; Bae YS
Diabetes; 2000 Sep; 49(9):1459-67. PubMed ID: 10969829
[TBL] [Abstract][Full Text] [Related]
12. Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection.
Yang K; Wang S; Chang KO; Lu S; Saif LJ; Greenberg HB; Brinker JP; Herrmann JE
Vaccine; 2001 Apr; 19(23-24):3285-91. PubMed ID: 11312027
[TBL] [Abstract][Full Text] [Related]
13. A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2.
Wong HT; Cheng SC; Sin FW; Chan EW; Sheng ZT; Xie Y
Vaccine; 2002 Jun; 20(21-22):2641-7. PubMed ID: 12034088
[TBL] [Abstract][Full Text] [Related]
14. Enhancing immune responses of EV71 VP1 DNA vaccine by co-inoculating plasmid IL-12 or GM-CSF expressing vector in mice.
Peng X; Fang X; Li J; Kong L; Li B; Ding X
Cell Mol Biol (Noisy-le-grand); 2016 Apr; 62(4):35-41. PubMed ID: 27188732
[TBL] [Abstract][Full Text] [Related]
15. Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor.
Mahon BP; Katrak K; Nomoto A; Macadam AJ; Minor PD; Mills KH
J Exp Med; 1995 Apr; 181(4):1285-92. PubMed ID: 7699320
[TBL] [Abstract][Full Text] [Related]
16. Comparison of various expression plasmids for the induction of immune response by DNA immunization.
Lee AH; Suh YS; Sung JH; Yang SH; Sung YC
Mol Cells; 1997 Aug; 7(4):495-501. PubMed ID: 9339893
[TBL] [Abstract][Full Text] [Related]
17. Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
Choi AH; Knowlton DR; McNeal MM; Ward RL
Virology; 1997 May; 232(1):129-38. PubMed ID: 9185596
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of DNA vaccine potency against herpes simplex virus 1 by co-administration of an interleukin-18 expression plasmid as a genetic adjuvant.
Zhu M; Xu X; Liu H; Liu X; Wang S; Dong F; Yang B; Song G
J Med Microbiol; 2003 Mar; 52(Pt 3):223-228. PubMed ID: 12621087
[TBL] [Abstract][Full Text] [Related]
19. Cloning and expression of the VP1 major capsid protein of diabetogenic encephalomyocarditis (EMC) virus and prevention of EMC virus-induced diabetes by immunization with the recombinant VP1 protein.
Jun HS; Yoon SW; Kang Y; Pak CY; Lee MC; Yoon JW
J Gen Virol; 1995 Oct; 76 ( Pt 10)():2557-66. PubMed ID: 7595359
[TBL] [Abstract][Full Text] [Related]
20. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
Choi AH; Basu M; Rae MN; McNeal MM; Ward RL
Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
